It should be emphasized that among these patients in 277 (74%) SV transplants harvested from the double-vessel CAD group and in 662 (70%) patients from the triple-vessel CAD, VEGFR-3 was not expressed within blood vessel wall (Fig. 10c). The gene discussed is FLT4; the disease is coronary artery disorder.